TYR115 IS THE KEY RESIDUE FOR DETERMINING AGONIST SELECTIVITY IN THE V1A VASOPRESSIN RECEPTOR

被引:158
|
作者
CHINI, B
MOUILLAC, B
ALA, Y
BALESTRE, MN
TRUMPPKALLMEYER, S
HOFLACK, J
ELANDS, J
HIBERT, M
MANNING, M
JARD, S
BARBERIS, C
机构
[1] INSERM,U401,F-34094 MONTPELLIER 05,FRANCE
[2] MARION MERRELL DOW RES INST,F-67080 STRASBOURG 05,FRANCE
[3] MED COLL OHIO,DEPT BIOCHEM,TOLEDO,OH 43699
来源
EMBO JOURNAL | 1995年 / 14卷 / 10期
关键词
AGONIST SELECTIVITY; DDAVP; MOLECULAR MODELING; RECEPTOR MUTAGENESIS; VASOPRESSIN RECEPTOR;
D O I
10.1002/j.1460-2075.1995.tb07211.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Using a three-dimensional model of G protein-coupled receptors (GPCR), we have previously succeeded in docking the neurohypophysial hormone arginine-vasopressin (AVP) into the V1a receptor, According to this model, the hormone is completely embedded in the transmembrane part of the receptor. Only the side chain of the Arg residue at position 8 projects outside the transmembrane core of the receptor and possibly interacts with a Tyr residue located in the first extracellular loop at position 115. Residue 8 varies in the two natural neurohypophysial hormones, AVP and oxytocin (OT); similarly, different residues are present at position 115 in the different members of the AVP/OT receptor family. Here we show that Arg8 is crucial for high affinity binding of AVP to the rat V1a receptor. Moreover, when Tyr115 is replaced by an Asp and a Phe, the amino acids naturally occurring in the V2 and in the OT receptor subtypes, the agonist selectivity of the V1a receptor switches accordingly, Our results indicate that the interaction between peptide residue 8 and the receptor residue at position 115 is not only crucial for agonist high affinity binding but also for receptor selectivity.
引用
收藏
页码:2176 / 2182
页数:7
相关论文
共 50 条
  • [31] Altered feeding behavior in mice lacking the V1a vasopressin receptor
    Aoyagi, T
    Birumachi, J
    Tanoue, A
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 189P - 189P
  • [32] Vasopressin V1a receptor gene and motivated behavior in mice and humans
    Masuki, Shizue
    Sumiyoshi, Eri
    Nose, Hiroshi
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2013, 63 : S107 - S107
  • [33] Vasopressin V1a receptor gene and voluntary exercise in humans and Mice
    Department of Sports Medical Sciences, Graduate School of Medicine and Institute for Biomedical Sciences, Shinshu University, 3-1-1 Asahi, Matsumoto
    Nagano
    390-8621, Japan
    不详
    Nagano
    390-8621, Japan
    Physical Activity, Exercise, Sedentary Behavior and Health, (251-262):
  • [34] V1a receptor agonists: The search for clean and green alternatives to vasopressin
    van Haren, Frank M. P.
    Mitchell, Imogen
    CRITICAL CARE MEDICINE, 2012, 40 (06) : 1999 - 2000
  • [35] The vasopressin V1a receptor is involved in the maintenance of resting blood pressure
    Oikawa, R
    Nasa, Y
    Kawahara, Y
    Hyuga, TK
    Tomita, Y
    Tanoue, A
    Hosoda, C
    Kubota, M
    Tsujimoto, G
    Takeo, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 122P - 122P
  • [36] Putative dynamics of vasopressin in its V1a receptor binding site
    Kaltenböck, A
    Hibert, M
    Langer, T
    RECEPTORS & CHANNELS, 2003, 9 (02): : 93 - 106
  • [37] Characterisation of the sheep vasopressin V1a receptor gene promoter region
    Koukoulas, I
    Johnston, CI
    Aldred, GP
    JOURNAL OF HYPERTENSION, 1998, 16 : S43 - S43
  • [38] Structure and sequence of the mouse V1a and V1b vasopressin receptor genes
    Kikuchi, S
    Tanoue, A
    Goda, N
    Matsuo, N
    Tsujimoto, G
    JAPANESE JOURNAL OF PHARMACOLOGY, 1999, 81 (04): : 388 - 392
  • [39] Key amino acids of vasopressin V1a receptor responsible for the species difference in the affinity of OPC-21268
    Shinoura, H
    Take, H
    Hirasawa, A
    Inoue, K
    Ohno, Y
    Hashimoto, K
    Tsujimoto, G
    FEBS LETTERS, 2000, 466 (2-3) : 255 - 258
  • [40] Expression of arginine vasopressin and vasopressin V1a receptor mRNA in diabetic (db/db) mice
    Morita, M
    Kita, Y
    Morikawa, N
    Iwami, M
    Notsu, Y
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2001, 109 (05) : 261 - 266